OBJECTIVE: The overall objective of this secondary analysis was to examine self-reported adherence to antiretroviral therapy in a sample of women with HIV. DESIGN: The primary study used survey methodology. SETTING: The setting included a university-based HIV/AIDS clinic in southwestern Pennsylvania and a community-based HIV/AIDS clinic in eastern Pennsylvania. PARTICIPANTS: Sixty-one women infected with HIV who were taking protease inhibitors. MAIN OUTCOME MEASURE: Self-reported adherence was based on responses to two questions: whether the person had missed a dose of her medications within the past 24 hours, and how many pills the person had taken on time as scheduled (none, very few, a few, about half, most, nearly all, all of them). RESULTS: Adherence ranged from 60% to 75%. Two thirds (65.6%) of the sample thought that their medications were helping them; three fifths (57.4%) thought that it was dangerous to miss a dose of their medications. CONCLUSIONS: Adherence in this sample was less than perfect, suggesting the need to develop, implement, and test interventions to promote better adherence to antiretroviral medication regimens among women with HIV.
OBJECTIVE: The overall objective of this secondary analysis was to examine self-reported adherence to antiretroviral therapy in a sample of women with HIV. DESIGN: The primary study used survey methodology. SETTING: The setting included a university-based HIV/AIDS clinic in southwestern Pennsylvania and a community-based HIV/AIDS clinic in eastern Pennsylvania. PARTICIPANTS: Sixty-one women infected with HIV who were taking protease inhibitors. MAIN OUTCOME MEASURE: Self-reported adherence was based on responses to two questions: whether the person had missed a dose of her medications within the past 24 hours, and how many pills the person had taken on time as scheduled (none, very few, a few, about half, most, nearly all, all of them). RESULTS: Adherence ranged from 60% to 75%. Two thirds (65.6%) of the sample thought that their medications were helping them; three fifths (57.4%) thought that it was dangerous to miss a dose of their medications. CONCLUSIONS: Adherence in this sample was less than perfect, suggesting the need to develop, implement, and test interventions to promote better adherence to antiretroviral medication regimens among women with HIV.
Authors: B Biswas; E Spitznagel; A C Collier; B B Gelman; J C McArthur; S Morgello; J A McCutchan; D B Clifford Journal: J HIV AIDS Soc Serv Date: 2014-01-01
Authors: Faith E Fletcher; Damon J Vidrine; Irene Tami-Maury; Heather E Danysh; Rachel Marks King; Meredith Buchberg; Roberto C Arduino; Ellen R Gritz Journal: AIDS Behav Date: 2014-03
Authors: Edward J Mills; Jean B Nachega; David R Bangsberg; Sonal Singh; Beth Rachlis; Ping Wu; Kumanan Wilson; Iain Buchan; Christopher J Gill; Curtis Cooper Journal: PLoS Med Date: 2006-11 Impact factor: 11.069